Fluoroquinolone Factive acquires approval from US FDA
LG Life Sciences said recently that Factive (gemifloxacin) received an approvable letter from the FDA via its American strategic partner GeneSoft.
In the wake...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
